Literature DB >> 23751473

[Trend and prediction on the incidence of pancreatic cancer in China].

Chen Ma1, Yong-xiao Jiang, Shu-zheng Liu, Pei-liang Quan, Xi-bin Sun, Rong-shou Zheng, Si-wei Zhang, Wan-qing Chen.   

Abstract

OBJECTIVE: To analyze and predict the incidence trends and burden of pancreatic cancer from 2008 to 2015.
METHODS: Registration data on pancreatic cancer of cancer registration in 1998 - 2007, were retrieved and utilized for analyzing the annual incidence of pancreatic cancer. Age-standardized rate by Chinese population (ASR) was calculated, using the direct method. JoinPoint software was applied for trend analysis. Bayesian Age-Period-Cohort Modeling Prediction Package was used to estimate age, period and cohort effects as well as to predict the incidence rates.
RESULTS: From 1998 to 2007, the annual incidence for men and women in urban areas showed an increase of 1.86% and 2.1% per year, but the increasing trend on the age-standardized rate was not obvious in both men and women. However, the incidence rates for men and women in rural areas increased by 7.54% and 7.83% and the age-standardized rates increased by 4.82% and 5.48% per year.
RESULTS: from the projection model showed that the trends were mainly caused by age, period and cohort effects. Based on the analysis, up to 2015, the annual new cases of pancreatic cancer would be 103 428 (60 500 for males and 42 928 for females), with 15 277 cases more than that of 2008.
CONCLUSION: There appeared an increasing trend of pancreatic cancer incidence which was more significant in the rural areas than the slowly increasing trend in the urban areas. The increasing trend of pancreatic cancer would be slow until the year 2015. However, in the short term pancreatic cancer is still a major cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23751473

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  5 in total

Review 1.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.

Authors:  Xiao-Yi Wang; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Pathogenic Microorganisms and Pancreatic Cancer.

Authors:  Chunsaie Wang; Jingna Li
Journal:  Gastrointest Tumors       Date:  2015-04-22

3.  A prognostic index model to predict the clinical outcomes for advanced pancreatic cancer patients following palliative chemotherapy.

Authors:  Peng Xue; Lifei Zhu; Zhiyong Wan; Weiyi Huang; Ning Li; Donghui Chen; Jiong Hu; Haiyan Yang; Liwei Wang
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-20       Impact factor: 4.553

4.  High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq.

Authors:  Yangxing Zhao; Jinfeng Sun; Hongyu Zhang; Shicheng Guo; Jun Gu; Wei Wang; Ning Tang; Xiaoyu Zhou; Jian Yu
Journal:  Clin Epigenetics       Date:  2014-09-22       Impact factor: 6.551

5.  Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer.

Authors:  Zheng He; Hui Wu; Yanli Jiao; Jun Zheng
Journal:  Oncol Lett       Date:  2014-12-01       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.